Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma

Fig. 2

a Differential expression of EZH2 in pan-cancer between tumor groups and normal groups b Differential expression of EZH2 in HCC between tumor group and normal group c Pairwise differential analysis of EZH2 in HCC d Overall survival curve e Overall survival curve f Protein expression between tumor group and normal group in HPA database (T: tumor, N: normal) (* p < 0.05; ** p < 0.01; *** p < 0.001)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us